| Home | Back To Index |

IT Software Tools for Life Science
and Drug Discovery R&D

Bioscience, Biotechnology, Pharmaceutical Company and Institute's
IT Software Tools, Strategy, and WW Market Outlook
Price: $ 1,495.00 (Hardcopy Print Edition)
$ 2,295.00 (PDF Single-Department License)
$ 3,495.00 (Corporate-Wide License)
Published: June 18, 2009
Total Page: 158 pages


Executive Summary

This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements.

The emergence of big-budget, life science and drug discovery R&D initiatives sponsored by world governments and other players, combined with the rapid deployments of many types of new analytical instruments has created an incredible set of drug discovery opportunities and challenges for academic labs, R&D institutes and drug making companies alike. Their enormous data output is driving the need to acquire key IT software tools and service solutions even in a major recession.

Big pharma and biotech companies continue to suffer from high R&D costs, drug patent expirations, lower new drug product output, more competition, regulatory challenges and other issues. A growing number of drug makers have turned to reorganizing their business models and are using powerful computer infrastructure and IT software solutions that will help transform their companies with next generation R&D capabilities. They hope to shorten their drug R&D timelines and reduce costs.

The study analyzes the market for IT software tools and services that enable life science and drug R&D. The report segments the software tools and services market by key R&D technology areas that map to drug R&D functions. The R&D tools, such as DNA arrays, next-generation sequencing, cell analysis, biomarkers, knowledge management, ELNs, LIMS and others are discussed.

This report discusses the interesting IT software topics with key findings. The study estimates that the worldwide IT software and services market for life science and drug R&D will reach $1.8 billion in 2009, with a strong growth rate. The research report is for marketers, business development, top executives, investors, VCs, consultants, R&D managers, or entrepreneurs. The report discusses a number of interesting customer case studies and includes 21 company profiles. This report uses 41 figures and tables to illustrate the findings. The study features many convenient tables that help the reader scan the details of key trends, market segmentation, revenue outlook, products, key customers and the like.

The IT Software Tools for Life Science & Drug Discovery R&D Market Ecosystem


Table of Contents

1. Overview of IT Software Tools for Life Science & Drug Discovery R&D
  1.1 Market Ecosystem of IT Software Tools for Life Science & Drug Discovery R&D
  1.2 Industry Drug Discovery R&D Applications
    1.2.1 Life Science and Drug Discovery R&D Steps
    1.2.2 Industrial Scale Drug R&D Factories
    1.2.3 Instrumentation Advances Are Driving Need for More IT Solutions
  1.3 IT Software Tools, Technologies, Equipment & Products for R&D
    1.3.1 R&D IT Infrastructure
    1.3.2 R&D IT Storage Systems Infrastructure
    1.3.3 R&D IT Application Software

2. Activities of IT Software Tools by Key Life Science R&D Segments
  2.1 Overview of IT Software Tools by Key Life Science R&D Segments
  2.2 Software Products by Technology Segments
      Table 1 Technology Segment/Category/Software Name/Software Vendor/Customers
        T1-1 DNA Array Analysis
        T1-2 Next Generation Sequecing
        T1-3 Epigenetics Analysis
        T1-4 Proteomics
        T1-5 Cell-Based Analysis
        T1-6 RNAi Analysis
        T1-7 Molecular Diagnostics & Testing
        T1-8 Genetic Biomarker R&D
        T1-9 R&D Data Integration
        T1-10 R&D Knowledge Management & Collaboration
        T1-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
  2.3 Software Products by Technology Segment & Customer Organization
      Table 2 Technology Segment/Category/Customer Organization/Software Name/Vendor
        T2-1 DNA Array Analysis
        T2-2 Next Generation Sequencing
        T2-3 Epigenetic Analysis
        T2-4 Proteomics
        T2-5 Cell-Based Analysis
        T2-6 RNAi Analysis
        T2-7 Molecular Diagnostics & Testing
        T2-8 Genetic Biomarker R&D
        T2-9 R&D Data Integration
        T2-10 R&D Knowledge Management & Collaboration
        T2-11 Others: R&D WorkFlow; LIMS; ELNs, etc
  2.4 Software Products by Technology Segment & Services Providers/ Outsourcers
      Table 3 Technology Segment/Category/Service Provider/Outsourcer/Service Detail
        T3-1 DNA Array Analysis
        T3-2 Next Generation Sequencing
        T3-3 Epigenetic Analysis
        T3-4 Proteomics
        T3-5 Cell-Based Analysis
        T3-6 RNAi Analysis
        T3-7 Molecular Diagnostic & Testing
        T3-8 Genetic Biomarker R&D
        T3-9 R&D Data Integration
        T3-10 R&D Knowledge Management & Collaboration
        T3-11 Others: R&D WorkFlow; LIMS; ELNs, Etc.

3. Case Studies
  3.1 Hospital for Sick Children Research Institute and Genologics
    3.1.1 Need for a New Informatics Software Solution
    3.1.2 The Solution That Was Selected
    3.1.3 Technology Review
    3.1.4 Results of Solution
  3.2 Human Genome Sequencing Center at the Baylor College of Medicine
      and Data Storage Solution
    3.2.1 Need for an IT Storage Systems Solution
    3.2.2 The Solution That Was Selected
    3.2.3 Technology Review
    3.2.4 Results of Solution
  3.3 Eli Lilly and Discovery Research Knowledge Management Solution
    3.3.1 Need for a Software Solution
    3.3.2 The Solution That Was Selected
    3.3.3 Technology Review
    3.3.4 Results of Solution
  3.4 Sanofi-Aventis and In Silico Drug Discovery
    3.4.1 Need for a Software Solution
    3.4.2 The Software Solution That Was Selected
    3.4.3 Technology Review
    3.4.4 Results of Solution
  3.5 Biogen Idec, Inc. and Tibco Spotfire DecisionSite
    3.5.1 Need for a Software Solution
    3.5.2 The Solution That Was Selected
    3.5.3 Technology Review
    3.5.4 Results of Solution

4. WW Software Tools & IT Services Market Forecast for Life Science and Drug R&D
  4.1 Methodology Used for This Report
    4.1.1 Methodology
    4.1.2 Definitions
    4.1.3 Research Information Sources
  4.2 WW Market Forecast (Total)
  4.3 WW Market Forecast by Technologies
    4.3.1 Revenues by Technology Segment, 2008-2013
    4.3.2 Market Shares by Technology Segments, 2008 & 2013
  4.4 WW Market Forecast by Customer Organization Segments
    4.4.1 Revenues by Customer Organization Segments, 2008-2013
      4.4.1.1 Academic, Government
      4.4.1.2 R&D Service Provider
      4.4.1.3 Pharma, Biotech
      4.4.1.4 Other
    4.4.2 Market Shares by Customer Organization Segments, 2008 & 2013
  4.5 WW Market Forecast by Regions
    4.5.1 Revenues by Regions, 2008-2013
      4.5.1.1 US
      4.5.1.2 Europe
      4.5.1.3 Asia Pacific
      4.5.1.4 ROW
    4.5.2 Market Shares by Region, 2008 & 2013

5. Company Profiles: IT Software Tools
  5.1 Equipment
    5.1.1 Affymetrix, Inc.
    5.1.2 Agilent Technologies, Inc., BAM/LS
    5.1.3 BlueArc Corporation
    5.1.4 Isilon Systems, Inc.
    5.1.5 Life Technologies, Inc.
    5.1.6 ThermoFisher Scientific Inc.
  5.2 Services
    5.2.1 BioTeam, Inc.
    5.2.2 Cogenics (Div. Of Clinical Data)
    5.2.3 Complete Genomics, Inc.
    5.2.4 GATC Biotech AG
    5.2.5 Genpathway, Inc.
    5.2.6 Ocimum Biosolutions Ltd.
  5.3 Software
    5.3.1 Accelrys, Inc.
    5.3.2 CLC bio 119
    5.3.3 DNASTAR, Inc.
    5.3.4 Entelos, Inc.
    5.3.5 Gene Codes Corporation
    5.3.6 GeneGo, Inc.
    5.3.7 Genomatix Software GmbH
    5.3.8 GenomeQuest, Inc.
    5.3.9 Symyx Technologies,Inc.

6. Conclusions

7. Addendum: Revenue Forecast Outlook Detail Tables by Technology Segements

8. Appendix 1
  8.1 Key Life Science R&D Centers
  8.2 Selected Company Links

9. Appendix 2
  9.1 Glossary - Life Science Terms

List of Tables

      Table 1 Technology Segment/Category/Software Name/Software Vendor/Customers
        T1-1 DNA Array Analysis
        T1-2 Next Generation Sequecing
        T1-3 Epigenetics Analysis
        T1-4 Proteomics
        T1-5 Cell-Based Analysis
        T1-6 RNAi Analysis
        T1-7 Molecular Diagnostics & Testing
        T1-8 Genetic Biomarker R&D
        T1-9 R&D Data Integration
        T1-10 R&D Knowledge Management & Collaboration
        T1-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
      Table 2 Technology Segment/Category/Customer Organization/Software Name/Vendor
        T2-1 DNA Array Analysis
        T2-2 Next Generation Sequecing
        T2-3 Epigenetics Analysis
        T2-4 Proteomics
        T2-5 Cell-Based Analysis
        T2-6 RNAi Analysis
        T2-7 Molecular Diagnostics & Testing
        T2-8 Genetic Biomarker R&D
        T2-9 R&D Data Integration
        T2-10 R&D Knowledge Management & Collaboration
        T2-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
      Table 3 Technology Segment/Category/Service Provider/Outsourcer/Service Detail
        T3-1 DNA Array Analysis
        T3-2 Next Generation Sequecing
        T3-3 Epigenetics Analysis
        T3-4 Proteomics
        T3-5 Cell-Based Analysis
        T3-6 RNAi Analysis
        T3-7 Molecular Diagnostics & Testing
        T3-8 Genetic Biomarker R&D
        T3-9 R&D Data Integration
        T3-10 R&D Knowledge Management & Collaboration
        T3-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
      Table 4 Rackable Compute Servers
      Table 5 Rackable Storage Servers
      Table 6 Total WW Market Forecast, 2008-2013
      Table 7 Revenues by Technology Segments , 2008-2013
      Table 8 Market Shares by Technology Segments, 2008 & 2013
      Table 9 Revenues by Customer Org. Segments, 2008-2013
      Table 10 Market Shares by Customer Org. Segments, 2008 & 2013
      Table 11 Revenues By Regions, 2008-2013
      Table 12 Market Shares by Regions, 2008 & 2013
      Table 13 Examples of Pharma Knowledge Management Systems
      Table 14 Selected Pre-Competitive R&D Information Sharing Arrangements
      Table 15 Addendum: DNA Array Analysis Revenue Detail, 2008-2013
      Table 16 Addendum: Next-Generation Sequencing Analysis Revenue Detail, 2008-2013
      Table 17 Addendum: Epigenetic Analysis Revenue Detail, 2008-2013
      Table 18 Addendum: Proteomics Analysis Revenue Detail, 2008-2013
      Table 19 Addendum: Cell-Based Analysis Revenue Detail, 2008-2013
      Table 20 Addendum: Genetic Biomarker R&D Revenue Detail, 2008-2013l
      Table 21 Addendum: RNAi Analysis Revenue Detail, 2008-2013
      Table 22 Addendum: Molecular Diagnostics Revenue Detail, 2008-2013
      Table 23 Addendum: R&D Data Integration; Content Mgt. Revenue Detail, 2008-2013
      Table 24 Addendum: R&D Knowledge Mgt. & Collab. Revenue Detail, 2008-2013
      Table 25 Addendum: R&D Other: Workflows, LIMS, ELNs Revenue Detail, 2008-2013
      Table 26 Large International Life Science R&D Centers
      Table 27 Selected Companies By Product Area
      Table 28 Glossary - Life Science Terms

List of Illustrations

      Figure 1 The IT Software Tools for Life Science & Drug Discovery R&D Market Ecosystem
      Figure 2 The Drug Research and Development Path to Final Approval
      Figure 3 The "Drug Discovery" Steps of the Drug R&D Process
      Figure 4 Rackable C1001 Compute Server
      Figure 5 Rackable S3012 Storage Server
      Figure 6 Mobius Quick Search - All Data View
      Figure 7 Tibco SpotFire DecisionSite
      Figure 8 Total WW Market Forecast, 2008-2013
      Figure 9 Market Revenues by Technology Segments, 2008-2013
      Figure 10 Market Shares by Technology Segments, 2008 & 2013
      Figure 11 Market Revenues by Customer Org. Segments, 2008-2013
      Figure 12 Market Shares by Customer Org. Segments, 2008 & 2013
      Figure 13 Market Revenues By Regions, 2008-2013
      Figure 14 Market Shares by Regions, 2008 & 2013
    

FOR ORDER OR INQUIRY, PLEASE CLICK "ORDER / INQUIRY FORM"